Justin D. Gover, Chief Executive Officer at GW PHARMACEUTICALS PLC (GWPH), sold 404,448 shares at $9.71 ($3.9M) on 2020-02-03, disclosed to the SEC on 2020-02-05.
Open-market sale of $3.9M GWPH by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.57 | 71,712 | $686K | 17.6% |
| 2 | $9.57 | 71,712 | $686K | 17.6% |
| 3 | $9.63 | 110,964 | $1.1M | 27.5% |
| 4 | $9.63 | 110,964 | $1.1M | 27.5% |
| 5 | $9.71 | 19,548 | $190K | 4.9% |
| 6 | $9.71 | 19,548 |
| $190K |
| 4.9% |
| Total | $9.62 avg | 404,448 | $3.9M | 100% |
| Filing → |
| GWPH | SELL | 2020-03-04 | $477K | — | Filing → |
| GWPH | SELL | 2020-02-28 | $194K | — | Filing → |
| GWPH | SELL | 2019-12-19 | $49K | — | Filing → |